Keywan Mortezaee

15 ta ish

Kurdistan University of Medical Sciences

1. Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer

   Keywan Mortezaee, Asghar Narmani, Majid Salehi +4

   Sharh maqola20218 iqtibos

   ABIABI:AkademIndex/2026.other.049165

2. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review

   Keywan Mortezaee, Masoud Najafi, Bagher Farhood +4

   Sharh maqolaOAOchiq kirish20196 iqtibos

   ABIABI:AkademIndex/2026.other.049142

3. The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review

   Masoud Najafi, Mohammad Reza Hooshangi Shayesteh, Keywan Mortezaee +2

   Sharh maqola20196 iqtibos

   ABIABI:AkademIndex/2026.other.049153

4. Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy

   Bagher Farhood, Keywan Mortezaee, Nasser Hashemi Goradel +5

   Sharh maqola20185 iqtibos

   ABIABI:AkademIndex/2026.other.049136

5. The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study

   Masoud Najafi, Keywan Mortezaee, Mahban Rahimifard +2

   Sharh maqola20205 iqtibos

   ABIABI:AkademIndex/2026.other.216858

6. Targets for improving tumor response to radiotherapy

   Keywan Mortezaee, Wrya Parwaie, Elahe Motevaseli +6

   Sharh maqola20194 iqtibos

   ABIABI:AkademIndex/2026.other.216850

7. Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization

   Keywan Mortezaee, Masoud Najafi, Bagher Farhood +3

   Sharh maqola20194 iqtibos

   ABIABI:AkademIndex/2026.other.267857

8. NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy

   Keywan Mortezaee, Nasser Hashemi Goradel, Peyman Amini +4

   Sharh maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.220529

9. Cancer stem cells (CSCs) in cancer progression and therapy

   Masoud Najafi, Bagher Farhood, Keywan Mortezaee

   Sharh maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.839607

10. Interleukin-2 therapy of cancer-clinical perspectives

    Jamal Majidpoor, Keywan Mortezaee

    Sharh maqola20212 iqtibos

    ABIABI:AkademIndex/2026.other.095639

11. A systematic review of radiation‐induced testicular toxicities following radiotherapy for prostate cancer

    Bagher Farhood, Keywan Mortezaee, Hamed Haghi‐Aminjan +5

    Sharh maqola20192 iqtibos

    ABIABI:AkademIndex/2026.other.263188

12. Steps in metastasis: an updated review

    Jamal Majidpoor, Keywan Mortezaee

    Sharh maqola20212 iqtibos

    ABIABI:AkademIndex/2026.other.267893

13. Angiogenesis as a hallmark of solid tumors - clinical perspectives

    Jamal Majidpoor, Keywan Mortezaee

    Sharh maqola20212 iqtibos

    ABIABI:AkademIndex/2026.other.267901

14. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization

    Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee +8

    Sharh maqola20182 iqtibos

    ABIABI:AkademIndex/2026.other.394934

15. Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization

    Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed Eleojo Musa +2

    Sharh maqola20192 iqtibos

    ABIABI:AkademIndex/2026.other.407718